Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Molecular Biomedicine
|
January 9, 2025
Cancer vaccines: platforms and current progress
Wanting Lei, Kexun Zhou, Ye Lei, et al.
NPJ Biofilms and Microbiomes
|
July 27, 2025
Gut microbiota shapes cancer immunotherapy responses
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Cancer Therapeutics
|
October 17, 2024
Pathogenesis and Systemic Treatment of Hepatocellular Carcinoma: Current Status and Prospects
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Cardiovascular Diabetology
|
June 6, 2026
Associations of cumulative exposure and dynamic trajectories of the combined atherogenic and frailty index with incident cardiometabolic multimorbidity: a longitudinal analysis based on the China Health and Retirement Longitudinal Study (CHARLS)
Xianjing Feng, Bi Deng, Yinghuan Pan, et al.
Advances in Therapy
|
October 19, 2021
Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United States
Weiting Liao, Wanting Lei, Mingyang Feng, et al.
Frontiers in Oncology
|
March 29, 2021
The Effects of Autophagy-Related Genes and lncRNAs in Therapy and Prognosis of Colorectal Cancer
Yang Yang, Mingyang Feng, LiangLiang Bai, et al.
Therapeutic Advances in Medical Oncology
|
September 20, 2024
Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma
Weiting Liao, Huiqiong Xu, David Hutton, et al.
Frontiers in Oncology
|
December 23, 2021
Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors
Weiting Liao, Huiqiong Xu, David Hutton, et al.
Cancer Immunology, Immunotherapy : CII
|
March 10, 2021
The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte
Baojuan Han, Lina Dong, Jing Zhou, et al.
Oncotarget
|
December 31, 2016
Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes
Jingxuan Wang, Kun Gao, Wanting Lei, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Molecular Biomedicine
|
January 9, 2025
Cancer vaccines: platforms and current progress
Wanting Lei, Kexun Zhou, Ye Lei, et al.
NPJ Biofilms and Microbiomes
|
July 27, 2025
Gut microbiota shapes cancer immunotherapy responses
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Cancer Therapeutics
|
October 17, 2024
Pathogenesis and Systemic Treatment of Hepatocellular Carcinoma: Current Status and Prospects
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Cardiovascular Diabetology
|
June 6, 2026
Associations of cumulative exposure and dynamic trajectories of the combined atherogenic and frailty index with incident cardiometabolic multimorbidity: a longitudinal analysis based on the China Health and Retirement Longitudinal Study (CHARLS)
Xianjing Feng, Bi Deng, Yinghuan Pan, et al.
Advances in Therapy
|
October 19, 2021
Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United States
Weiting Liao, Wanting Lei, Mingyang Feng, et al.
Frontiers in Oncology
|
March 29, 2021
The Effects of Autophagy-Related Genes and lncRNAs in Therapy and Prognosis of Colorectal Cancer
Yang Yang, Mingyang Feng, LiangLiang Bai, et al.
Therapeutic Advances in Medical Oncology
|
September 20, 2024
Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma
Weiting Liao, Huiqiong Xu, David Hutton, et al.
Frontiers in Oncology
|
December 23, 2021
Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors
Weiting Liao, Huiqiong Xu, David Hutton, et al.
Cancer Immunology, Immunotherapy : CII
|
March 10, 2021
The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte
Baojuan Han, Lina Dong, Jing Zhou, et al.
Oncotarget
|
December 31, 2016
Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes
Jingxuan Wang, Kun Gao, Wanting Lei, et al.
Page
of 2